Home > Boards > US Listed > Medical - Equipment > INVO Bioscience Inc. (INVO)

Get certification for your medical device globally. https://www.operonstrategist.com/cdsco-licen

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
nehadesh Member Profile
 
Followed By 0
Posts 4
Boards Moderated 0
Alias Born 11/01/18
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/2/2021 5:10:47 PM
INVO Bio jumps 10% after obtaining regulatory approval to commercialize INVOcell in Thailand Seeking Alpha - 12/1/2021 9:29:29 AM
INVO Bioscience Obtains Regulatory Approval to Commercialize INVOcell In Thailand PR Newswire (US) - 12/1/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2021 6:13:06 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/15/2021 4:36:55 PM
INVO BioScience EPS misses by $0.04, misses on revenue Seeking Alpha - 11/15/2021 4:30:19 PM
INVO Bioscience Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update PR Newswire (US) - 11/15/2021 4:05:00 PM
INVO Bioscience to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021 PR Newswire (US) - 11/9/2021 4:15:00 PM
INVO Bioscience shares rise 11% after INVOcell U.S. commercialization rights update Seeking Alpha - 11/8/2021 4:36:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2021 4:16:04 PM
INVO Bioscience Regains Full U.S. Commercialization Rights PR Newswire (US) - 11/8/2021 4:15:00 PM
INVO Bioscience Announces Four Individual Poster Abstracts Discussing the Benefits of INVOcell Presented at the 2021 American Society for Reproductive Medicine (ASRM) Congress & Expo PR Newswire (US) - 10/20/2021 9:00:00 AM
INVO Bioscience Announces Grand Opening of "Positib Fertility, an INVO Center" in Monterrey, Mexico on November 1, 2021 PR Newswire (US) - 10/14/2021 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/7/2021 4:58:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/7/2021 4:58:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/5/2021 5:29:23 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/5/2021 5:11:48 PM
INVO Bioscience Announces $4.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules PR Newswire (US) - 10/1/2021 9:29:00 AM
INVO Bioscience Advances INVOcellĀ® Commercialization Efforts With Acquisition in Canada PR Newswire (US) - 9/9/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/7/2021 4:59:43 PM
INVO Bioscience Announces Official Opening of "Bloom Fertility, an INVO Center" in Atlanta PR Newswire (US) - 9/7/2021 9:00:00 AM
Dr. Inger Britt Carlsson, Vice President of Global Medical Affairs for INVO Bioscience, to Present at the 11th Annual AFRH Virtual Conference PR Newswire (US) - 9/3/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 4:12:35 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2021 4:05:40 PM
INVO Bioscience Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update PR Newswire (US) - 8/16/2021 4:05:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences